User account menu Search Menu Novartis Pharmaceuticals When science and passion connect, innovation happens Home About Innovative Medicines Novartis Pharmaceuticals Novartis Pharmaceuticals brings innovative medicines to market to enhance health outcomes for patients and offer solutions to the healthcare providers who treat them. AveXis is now Novartis Gene Therapies Novartis Gene Therapies is dedicated to developing and commercializing gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. Learn More Novartis Global Product Portfolio and Clinical Pipeline 155 Countries in which products are available See Our Medicines 30 New molecular entities in our global clinical pipeline Explore Our Pipeline Therapeutic areas At Novartis, we invest in the most promising frontiers of science, the most exciting innovations in the business of medicine, and the most significant healthcare needs. Through our focused portfolio, we’re reimagining drug development across five therapeutic areas. Cardiovascular, Renal and Metabolism Cardiovascular (CV), renal and metabolic diseases are a global health crisis. Billions of people are affected physically, emotionally and financially. These chronic, complex, debilitating and often hereditary diseases are frequently inter-related. Yet there continues to be healthcare system and treatment barriers, and a lack of transformative medicines. Thanks to a combination of our legacy, global footprint and leading science, Novartis is uniquely positioned to help change this landscape. Our efforts include use of early interventions and development of pioneering treatments that address the spectrum of CRM diseases, from prevention to management, as well as the creation of innovative access models. Our goal is to reduce and ultimately stop premature death and disability from CV disease. Immunology and Dermatology Novartis is a global leader in immunology and dermatology. We are transforming the lives of people living with immunologic diseases, focusing on specialty dermatology, rheumatology, autoinflammatory, transplant, and specialty liver diseases where there remain high unmet medical needs. Ophthalmology Novartis is reimagining the treatment and prevention of visual impairment and blindness. We aim to develop life-changing pharmaceuticals and transformative technologies for diseases and conditions from front to back of the eye. Neuroscience Novartis has been tackling neurological conditions for more than 80 years. Above all, partnering with patients, healthcare professionals and healthcare systems to deliver life-changing solutions and treatments is at the core of what we do. Together, we can innovate to reimagine neuroscience and improve people’s lives Respiratory At Novartis, our focus is on improving the lives of the hundreds of millions of people living with respiratory diseases, including chronic obstructive pulmonary disease (COPD) and severe allergic asthma. Stories A fitness trainer strives to keep his mother’s mind limber Awards and Recognition Novartis is honored to receive numerous awards for progress in research and development, our working environment, and our corporate responsibility activities. Subscribe to Novartis news. Get the latest news and updates from Novartis directly to your inbox. Recent Jobs in Pharmaceuticals When science and passion connect, innovation happens. Join us. Principal Clinical Data Manager Research & Development, India, Global Drug Development Business Manager - Oncology Commercial & General Management, India, ONCOLOGY Principal Clinical Data Manager Research & Development, India, Global Drug Development 县域主任 Sales, China, PHARMA See More Jobs Novartis Navigate Patients and Caregivers Healthcare Professionals Researchers Job Seekers Journalists Investors Partners Suppliers Topics Clinical Trials COVID-19 Info Center ESG Explore Stories Diseases Locations Companies Sandoz Advanced Accelerator Applications Footer Bottom © 2021 Novartis AG Terms of Use Privacy Contacts Cookie Settings Site Map Novartis Site Directory This site is intended for a global audience